表紙:創傷閉鎖市場- 世界および地域別分析 - 分析と予測(2024年~2030年)
市場調査レポート
商品コード
1397893

創傷閉鎖市場- 世界および地域別分析 - 分析と予測(2024年~2030年)

Wound Closure Market - A Global and Regional Analysis - Analysis and Forecast, 2024-2030

出版日: 受注後更新 | 発行: BIS Research | ページ情報: 英文 | 納期: 7~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
創傷閉鎖市場- 世界および地域別分析 - 分析と予測(2024年~2030年)
出版日: 受注後更新
発行: BIS Research
ページ情報: 英文
納期: 7~10営業日
  • 全表示
  • 概要
  • 目次
概要

世界の創傷閉鎖の市場規模は、慢性創傷の増加、高齢化人口の増加、創傷閉鎖技術の進歩などを背景に、近年大きな成長を遂げています。

創傷閉鎖市場には、縫合糸、ステープル、接着剤、創傷閉鎖用ストリップなど、創傷の治癒を促進するために設計された幅広い製品と技術が含まれます。慢性疾患の世界の増加や外科手術の急増に伴い、効果的で革新的な創傷閉鎖ソリューションへの需要が高まっています。

当レポートでは、世界の創傷閉鎖市場について調査し、市場の概要とともに、用途別、製品タイプ別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

エグゼクティブサマリー

範囲と定義

市場/製品の定義

主な質問への回答

分析と予測に関するメモ

第1章 市場:業界の展望

  • 動向:現在および将来の影響評価
  • サプライチェーンの概要
  • 研究開発レビュー
  • 規制状況
  • ステークホルダーの分析
  • 市場力学の概要
  • スタートアップ資金調達の概要

第2章 創傷閉鎖市場、製品タイプ別

  • 製品のセグメンテーション
  • 製品概要
  • 縫合
  • 止血剤
  • 接着剤およびシーラント

第3章 創傷閉鎖市場、調節経路およびデバイスクラス別

  • 規制経路の概要(510k、De Novoなど)
  • デバイスクラスの概要

第4章 創傷閉鎖市場、用途別

  • 用途と最終用途のセグメンテーション
  • 慢性創傷
  • 急性創傷
  • 病院と診療所
  • 外来

第5章 創傷閉鎖市場、地域別

  • 地域別の概要
  • 促進要因と抑制要因
  • 北米
  • 欧州
  • アジア太平洋

第6章 市場-競合情勢と企業プロファイル

  • 競合情勢
  • 市場シェア分析
  • 企業プロファイル
    • Medtronic
    • Smith and Nephew
    • Molnlycke
    • 3M
    • UsL Medical
    • Advin Healthcare
    • Acell, Inc.
    • Advamedica Inc.
    • Unisur Lifecare
    • Assult Medical Sarl
    • Obex
    • Johnson and Johnson

第7章 成長の機会と提言

第8章 調査手法

目次
Product Code: BHM1699SA

The global wound closure market has witnessed significant growth in recent years, driven by an increasing prevalence of chronic wounds, a growing aging population, and advancements in wound closure technologies. This report provides a comprehensive analysis of the current market landscape, key trends, competitive dynamics, and future opportunities in the wound closure market.

The wound closure market encompasses a wide range of products and technologies designed to facilitate the healing of wounds, including sutures, staples, adhesives, and wound closure strips. With a rising global burden of chronic diseases and a surge in surgical procedures, the demand for effective and innovative wound closure solutions has intensified.

Market Segmentation:

Segmentation 1: by Application

  • Chronic Wound
  • Acute Wound

Segmentation 2: by Product Type

  • Suture
  • Haemostat
  • Adhesive and Sealant

Segmentation 3: by Region

  • North America
  • Europe
  • Asia-Pacific

Competitive Landscape:

The wound closure market is characterized by intense competition among key players. Leading companies are investing in research and development to introduce novel products and gain a competitive edge. Strategic collaborations, mergers, and acquisitions are also prevalent strategies to expand market presence.

Key Questions Answered:

  • What are the major market drivers, challenges and opportunities in the global wound closure market?
  • How the wound closure market evolves and what did is its scope in the future?
  • How will each segment of the global wound closure market grow during the forecast period?
  • What are the influencing factors that may affect the market share of the key players?
  • How will the industry evolve during the forecast period?
  • What are the key developmental strategies implemented by the key players to stand out in this market?

Table of Contents

Executive Summary

Scope and Definition

Market/Product Definition

Key Questions Answered

Analysis and Forecast Note

1. Markets: Industry Outlook

  • 1.1. Trends: Current and Future Impact Assessment
  • 1.2. Supply Chain Overview
    • 1.2.1. Value chain Analysis
    • 1.2.2. Market Map
    • 1.2.3. Pricing Forecast
  • 1.3. R&D Review
    • 1.3.1. Patent Filing Trend by Country, by Company
  • 1.4. Regulatory Landscape
  • 1.5. Stakeholder Analysis
    • 1.5.1. End User and buying criteria
  • 1.6. Market Dynamics Overview
    • 1.6.1. Market Drivers
    • 1.6.2. Market Restraints
    • 1.6.3. Market Opportunities
  • 1.7. Startup Funding Summary

2. Wound Closure Market by Product Type

  • 2.1. Product Segmentation
  • 2.2. Product Summary
  • 2.3. Suture
    • 2.3.1. Suture by Application
    • 2.3.2. Suture by Brand
    • 2.3.3. Pricing Analysis
  • 2.4. Haemostat
    • 2.4.1. Haemostat by Application
    • 2.4.2. Haemostat by Brand
    • 2.4.3. Pricing Analysis
  • 2.5. Adhesive and Sealant
    • 2.5.1. Adhesive and Sealant by Application
    • 2.5.2. Adhesive and Sealant by Brand
    • 2.5.3. Pricing Analysis

3. Wound closure market by Regulatory pathways and device class

  • 3.1. Regulatory Pathway Summary (510k, De Novo etc)
  • 3.2. Device Class Summary

4. Wound Closure Market by Application

  • 4.1. Application and End use Segmentation
  • 4.2. Chronic Wound
  • 4.3. Acute Wound
  • 4.4. Hospital and Clinics
  • 4.5. Ambulatory

5. Wound Closure Market by Region

  • 5.1. Regional Summary
  • 5.2. Drivers and Restraints
  • 5.3. North America
    • 5.3.1. Markets
      • 5.3.1.1. Key Market Participants in North America
      • 5.3.1.2. Business Drivers
      • 5.3.1.3. Business Challenges
    • 5.3.2. Application
    • 5.3.3. Product
    • 5.3.4. North America by Country
      • 5.3.4.1. U.S.
      • 5.3.4.2. Canada
  • 5.4. Europe
    • 5.4.1. Markets
      • 5.4.1.1. Key Market Participants in Europe
      • 5.4.1.2. Business Drivers
      • 5.4.1.3. Business Challenges
    • 5.4.2. Application
    • 5.4.3. Product
    • 5.4.4. Europe by Country
      • 5.4.4.1. U.K.
      • 5.4.4.2. Germany
      • 5.4.4.3. France
  • 5.5. Asia-Pacific
    • 5.5.1. Markets
      • 5.5.1.1. Key Market Participants in Asia-Pacific
      • 5.5.1.2. Business Drivers
      • 5.5.1.3. Business Challenges
    • 5.5.2. Application
    • 5.5.3. Product
    • 5.5.4. Asia-Pacific by Country
      • 5.5.4.1. China
      • 5.5.4.2. Japan
      • 5.5.4.3. India

6. Markets - Competitive Landscape & Company Profiles

  • 6.1. Competitive Landscape
  • 6.2. Market Share Analysis
  • 6.3. Company Profiles
    • 6.3.1. Medtronic
      • 6.3.1.1. Company Overview
      • 6.3.1.2. Top Products / Product Portfolio
      • 6.3.1.3. Top Competitors
      • 6.3.1.4. Target Customers /End-Users
      • 6.3.1.5. Key Personnel
      • 6.3.1.6. Market Share
      • 6.3.1.7. Analyst View
    • 6.3.2. Smith and Nephew
      • 6.3.2.1. Company Overview
      • 6.3.2.2. Top Products / Product Portfolio
      • 6.3.2.3. Top Competitors
      • 6.3.2.4. Target Customers /End-Users
      • 6.3.2.5. Key Personnel
      • 6.3.2.6. Market Share
      • 6.3.2.7. Analyst View
    • 6.3.3. Molnlycke
      • 6.3.3.1. Company Overview
      • 6.3.3.2. Top Products / Product Portfolio
      • 6.3.3.3. Top Competitors
      • 6.3.3.4. Target Customers /End-Users
      • 6.3.3.5. Key Personnel
      • 6.3.3.6. Market Share
      • 6.3.3.7. Analyst View
    • 6.3.4. 3M
      • 6.3.4.1. Company Overview
      • 6.3.4.2. Top Products / Product Portfolio
      • 6.3.4.3. Top Competitors
      • 6.3.4.4. Target Customers /End-Users
      • 6.3.4.5. Key Personnel
      • 6.3.4.6. Market Share
      • 6.3.4.7. Analyst View
    • 6.3.5. UsL Medical
      • 6.3.5.1. Company Overview
      • 6.3.5.2. Top Products / Product Portfolio
      • 6.3.5.3. Top Competitors
      • 6.3.5.4. Target Customers /End-Users
      • 6.3.5.5. Key Personnel
      • 6.3.5.6. Market Share
      • 6.3.5.7. Analyst View
    • 6.3.6. Advin Healthcare
      • 6.3.6.1. Company Overview
      • 6.3.6.2. Top Products / Product Portfolio
      • 6.3.6.3. Top Competitors
      • 6.3.6.4. Target Customers /End-Users
      • 6.3.6.5. Key Personnel
      • 6.3.6.6. Market Share
      • 6.3.6.7. Analyst View
    • 6.3.7. Acell, Inc.
      • 6.3.7.1. Company Overview
      • 6.3.7.2. Top Products / Product Portfolio
      • 6.3.7.3. Top Competitors
      • 6.3.7.4. Target Customers /End-Users
      • 6.3.7.5. Key Personnel
      • 6.3.7.6. Market Share
      • 6.3.7.7. Analyst View
    • 6.3.8. Advamedica Inc.
      • 6.3.8.1. Company Overview
      • 6.3.8.2. Top Products / Product Portfolio
      • 6.3.8.3. Top Competitors
      • 6.3.8.4. Target Customers /End-Users
      • 6.3.8.5. Key Personnel
      • 6.3.8.6. Market Share
      • 6.3.8.7. Analyst View
    • 6.3.9. Unisur Lifecare
      • 6.3.9.1. Company Overview
      • 6.3.9.2. Top Products / Product Portfolio
      • 6.3.9.3. Top Competitors
      • 6.3.9.4. Target Customers /End-Users
      • 6.3.9.5. Key Personnel
      • 6.3.9.6. Market Share
      • 6.3.9.7. Analyst View
    • 6.3.10. Assult Medical Sarl
      • 6.3.10.1. Company Overview
      • 6.3.10.2. Top Products / Product Portfolio
      • 6.3.10.3. Top Competitors
      • 6.3.10.4. Target Customers /End-Users
      • 6.3.10.5. Key Personnel
      • 6.3.10.6. Market Share
      • 6.3.10.7. Analyst View
    • 6.3.11. Obex
      • 6.3.11.1. Company Overview
      • 6.3.11.2. Top Products / Product Portfolio
      • 6.3.11.3. Top Competitors
      • 6.3.11.4. Target Customers /End-Users
      • 6.3.11.5. Key Personnel
      • 6.3.11.6. Market Share
      • 6.3.11.7. Analyst View
    • 6.3.12. Johnson and Johnson
      • 6.3.12.1. Company Overview
      • 6.3.12.2. Top Products / Product Portfolio
      • 6.3.12.3. Top Competitors
      • 6.3.12.4. Target Customers /End-Users
      • 6.3.12.5. Key Personnel
      • 6.3.12.6. Market Share
      • 6.3.12.7. Analyst View

7. Growth Opportunities & Recommendations

8. Research Methodology